Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
2.540
+0.090 (3.67%)
At close: May 12, 2025, 4:00 PM
2.460
-0.080 (-3.15%)
After-hours: May 12, 2025, 7:41 PM EDT
Mainz Biomed Revenue
In the year 2024, Mainz Biomed had annual revenue of $893.99K, down -0.17%. Mainz Biomed had revenue of $186.61K in the quarter ending December 31, 2024, a decrease of -13.11%.
Revenue (ttm)
$893.99K
Revenue Growth
-0.17%
P/S Ratio
2.75
Revenue / Employee
$34,384
Employees
26
Market Cap
7.72M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MYNZ News
- 13 days ago - Mainz Biomed Enters into Technology Partnership with EDX Medical Group - GlobeNewsWire
- 14 days ago - Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval - GlobeNewsWire
- 6 weeks ago - Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - GlobeNewsWire
- 2 months ago - Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer - GlobeNewsWire
- 2 months ago - Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention - GlobeNewsWire
- 2 months ago - Mainz Biomed Expands into Switzerland with labor team w - GlobeNewsWire
- 3 months ago - Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month - GlobeNewsWire
- 3 months ago - Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements - GlobeNewsWire